Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

AHCL ☆ NSE also on BSE

ANLON HEALTHCARE LIMITED · code 758968 · INE0Y8W01025 · Pharma & Healthcare · series EQ · Daily price history

25.17 +0.20 (+0.80%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
44

ISA Signal Score: Weak

Caution: avoid adding, review holdings. Based on prices to 2026-11-20. Confidence 100%.

Trend10
Momentum56
52-week range8
Volume73
Risk25
Fundamentals90

Working for it

  • 50-day average is rising
  • Up 73% in 3 months
  • More volume on up days than down days (accumulation)
  • Profit grew 39% year on year
  • Revenue grew 43% year on year
  • Low debt

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • Price is below its 200-day average (long-term weakness)
  • 50-day average is below the 200-day average
  • MACD is negative and weakening
  • 85% below its 52-week high

Red flags

  • Down 85% from its 52-week high and still weakening

Measured reference levels (not forecasts): 20-day low 24.41, 52-week high 168.61, typical daily move 1.30, two typical moves below price 22.57.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 18.4%, ROCE 23.3%, debt 0.19x equity
GrowthFastSales 15.1%, profit 69.8% a year over 3 years
ValuationFairP/E 42.0 vs sector median 50.7
MomentumWeakBelow its 200-day average, lagged NIFTY 50 by 82.4 points
RiskHighSwings 105% a year, fell up to 92% from a peak, beta 0.99

Smart Investor Tips: AHCL

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Strong earnings compounding: net profit grew at 69.8% CAGR over 3 years.
  • High capital efficiency: ROE of 18.4% indicates strong returns on shareholder equity.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Long-term downtrend: price is below its 200-day average (Rs 47.64). Wait for a base formation and reclaim of the 50-day average (Rs 26.36) before committing fresh capital.
  • Deep drawdown (-85.4% from 52-week high). Verify earnings trend and balance-sheet debt before treating a low price as a bargain.
  • High 30-day annualized volatility (57%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceWEAK / REDUCE ON BOUNCES (Score 34/100)

Weak trend, debt overhang, or distribution. Avoid fresh buying until price reclaims 50-DMA (Rs 26.36). If already held, protect capital if it breaks below Rs 21.19 or trim near resistance Rs 28.40.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 23.14 – Rs 25.17
Ideal ~Rs 24.16
Rs 25.17 Rs 23.14 Rs 21.19
ATR 5.2%
Rs 29.51 Rs 172.75 1 : 1.8
RSI 46 · Vol 1.57x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +86.6% · high 37.24 · low 13.14 · max drawdown -33.1%

Live Candlestick & TradingView Chart (AHCL)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 20 Nov

P/E42.0sector median 50.7
P/B-price / book value
EPSRs 0.60grew 76.0% a year
Dividend yield-from saved dividend events
Debt to equity0.19xnet debt Rs 39.3 Cr
Sales growth15.1%a year over 3 years
Profit growth69.8%a year over 3 years
Operating margin27.2%net margin 16.6%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 0.60. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Adequate Debt & Cash Position · Score 69/100
Total Debt / Loans Rs 43.7 Cr Reduced Rs 22.9 Cr YoY
Cash & Bank Balances Rs 4.38 Cr Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 39.3 Cr 11.7% of total assets
Debt to Equity & Interest Cover 0.19x D/E Interest cover: 16.5x EBIT
Operating Cash Flow (OCF) Rs -79.4 Cr OCF/PAT conversion: -279%
Free Cash Flow (FCF) Rs -116 Cr After Capex of Rs 36.5 Cr
  • Low Debt-to-Equity (0.19x).
  • De-leveraging: reduced total debt by Rs 22.9 Cr YoY.
  • Strong loan interest coverage (16.5x EBIT/Interest).
  • Weak cash conversion (-168% OCF/PAT) - profits are tied up in receivables or inventory.
  • Free Cash Flow is Rs -116 Cr due to Capex investment of Rs 36.5 Cr.

About ANLON HEALTHCARE

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed03 Sep 2025BSE not available · NSE 03 Sep 2025
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 52.68% 0.00 pp, public 47.32%, as on 30 Sep 2026. Holder names and history

Day range24.00 to 25.51Open 24.83
52-week high172.75 -85.4% from high (28 Nov 2025)
52-week low12.91 +95.0% from low (28 Apr 2026)
Volume48.47 L 1.1x the 20-day average
RSI (14)45 neutral
Volatility (30d)56.7%annualised
12.91
172.75

Returns

1W-6.6%
1M-1.8%
3M+76.3%
6M+80.9%
1Y-83.9%
YTD-83.3%

Against the NIFTY 50

PeriodAHCLNIFTY 50Difference
1M-1.8%+13.1% -14.9 pts
3M+76.3%+6.4% +69.9 pts
6M+80.9%+8.8% +72.2 pts
1Y-83.9%-1.5% -82.4 pts

Risk over the past year

Volatility105%high
Deepest fall-92.2%from a peak
Beta0.99moves with the index
Best day+14.6%21 Sep 2026
Worst day-89.0%24 Apr 2026
Up days51%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 4 / 9 · Weak / Watch Balance Sheet
3-Step DuPont ROE Identity: High Pricing Power & Margin Leader
Net Margin: 16.6% × Asset Turnover: 0.46x × Equity Multiplier: 1.62x = ROE 18.4%
✓ Positive Net Profit (PAT > 0) Rs 28.5 Cr
⚠ Positive Operating Cash Flow (OCF > 0) Rs -79.4 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT) -279% conversion
⚠ Improving Return on Assets (ROA YoY) 7.6% vs 11.3%
✓ Conservative / Decreasing Debt-to-Equity 0.19x (prev 0.83x)
✓ Healthy Balance Sheet Asset Coverage 3.48x
✓ Institutional Return on Equity (ROE >= 14%) 18.4%
⚠ Stable / Expanding Profit Margin YoY 16.6% vs 17.1%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.46x

Quarterly Results (Last 7 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 49.033.052.036.051.088.0106
Sales QoQ % --32.7%+57.6%-30.8%+41.7%+72.5%+20.5%
Operating Profit 17.06.0013.013.015.016.025.0
Operating Margin (OPM %) 34.7%18.2%25.0%36.1%29.4%18.2%23.6%
Net Profit (PAT) 17.04.009.005.0011.08.0017.0
Profit QoQ % --76.5%+125.0%-44.4%+120.0%-27.3%+112.5%
Profit YoY % -----35.3%+100.0%+88.9%
Net Margin % 34.7%12.1%17.3%13.9%21.6%9.1%16.0%

Sales and profit Rs crore, consolidated

Sales growth+15.1%a year, 3Y
Profit growth+69.8%a year, 3Y
EPS growth+76.0%a year, 3Y
Avg ROE51.5%4 years

Profit and loss

Rs croreFY23FY24FY25FY26
Sales11366.6120172
Sales growth--41.0%+80.7%+43.0%
Operating profit12.715.732.146.8
Operating margin11.2%23.6%26.7%27.2%
Other income----
Interest3.794.083.442.74
Depreciation1.871.891.771.52
Profit before tax6.999.7526.942.5
Tax rate16.7%0.9%23.7%31.6%
Net profit5.829.6620.528.5
Profit growth-+66.0%+112.4%+38.9%
Net margin5.2%14.5%17.1%16.6%
EPS (Rs)0.110.180.390.60

Balance sheet

Rs croreFY23FY24FY25FY26
Equity (net worth)7.3721.080.4230
Borrowings70.381.366.643.7
Cash4.533.122.364.38
Total assets112128181374
Debt to equity9.54x3.86x0.83x0.19x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY23FY24FY25FY26
Operating Cash Flow (OCF)-2.85-3.23-22.6-79.4
Capital Expenditure (Capex)0.373.530.5336.5
Free Cash Flow (FCF = OCF - Capex)-3.22-6.76-23.1-116
OCF / Net Profit Conversion-0.49x-0.33x-1.10x-2.79x
Total Borrowings / Loans70.381.366.643.7
Cash & Bank Balances4.533.122.364.38
Trade Receivables (Cr)43.838.775.0104
Receivable Days141.66x212.32x227.58x220.06x
Inventories (Cr)27.041.750.3113
Inventory Days87.21x228.66x152.51x240.18x

Returns on capital

Rs croreFY23FY24FY25FY26
ROE79.0%68.0%40.5%18.4%
ROCE15.9%19.0%30.5%23.3%
Interest cover2.84x3.39x8.82x16.51x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLAURUS LABS LIMITED 2,294.60 -0.5% - 123,667 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZYDUS LIFESCIENCES LTD 1,200.00 -0.2% - 120,720 31.5 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS 2,648.00 +1.5% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD 825.00 +1.9% - 62,284 59.8 - 7.8% 11.7%
GLANDGLAND PHARMA LIMITED 3,331.90 +1.2% - 54,880 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMA LT 2,727.60 +0.5% - 46,208 78.3 26.0 33.2% 17.1%
EMCUREEMCURE PHARMACEUTICALS L 2,337.80 -0.3% - 44,351 47.9 9.0 19.0% 10.2%
SAILIFESAI LIFE SCIENCES LIMITED 1,800.70 +0.7% - 38,250 109.3 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LIMITED 2,184.40 -0.1% - 35,495 166.5 7.2 4.3% 6.4%
GRANULESGRANULES INDIA LIMITED 822.65 +2.7% - 19,939 34.3 3.9 11.7% 11.1%
ALIVUSALIVUS LIFE SCIENCES LTD 1,436.90 -0.9% - 17,609 37.4 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,029.10 -2.7% - 15,411 33.7 6.7 19.7% 27.0%
AHCLANLON HEALTHCARE LIMITED 25.17 +0.8% - - 42.0 - 12.4% 16.6%
Sector median- 50.77.012.4%

The 13 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is below its 200-day average (long-term downtrend) RSI 45: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower quarter of its 1-year range and is lower than it was on 55% of days in the past year.

Support (prices below today's)

20-day low23.14-8.1%
60-day low14.97-40.5%
52-week low12.91-48.7%

Resistance (prices above today's)

50-day average26.36+4.7%
20-day high28.40+12.8%
60-day high37.24+48.0%
200-day average47.64+89.3%

Zones buyers often watch

Lower quarter of the 1-year range 12.91 to 52.87 price is inside this zone now
Pullback of 10% to 20% from the high 138.20 to 155.48 A common area for dips inside an uptrend.
Around the 200-day average 46.21 to 49.07 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -92.2%. Currently -85.1% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average25.82 Price is 2.5% below
50-day average26.36 Price is 4.5% below
200-day average47.64 Price is 47.2% below
RSI (14)45Neutral
MACD (12, 26, 9)-0.15Below its signal line (momentum fading)
Volatility (30d)56.7%High yearly swings

Support and resistance

R226.40
R125.79
Pivot24.89
S124.28
S223.38

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 24.83 25.51 24.00 25.17 +0.80% 4,846,543
2026-11-19 25.33 25.77 24.80 24.97 -1.89% 2,077,848
2026-11-18 25.44 26.00 25.03 25.45 -0.43% 1,741,642
2026-11-17 25.68 26.19 25.37 25.56 -0.81% 2,631,635
2026-11-16 26.98 27.26 25.60 25.77 -4.34% 2,799,165
2026-11-13 26.57 27.20 26.32 26.94 +0.79% 2,364,328
2026-11-12 27.36 27.73 26.58 26.73 -0.78% 2,170,009
2026-11-11 27.15 27.60 26.61 26.94 +0.04% 3,038,704
2026-11-09 28.00 28.20 26.60 26.93 -3.23% 3,227,219
2026-11-06 28.30 28.40 26.75 27.00 -3.54% 4,468,240
2026-11-05 27.05 27.99 26.61 27.99 +4.99% 4,337,420
2026-11-04 25.31 26.67 25.00 26.66 +4.96% 5,053,143
2026-11-03 25.10 25.92 24.89 25.40 +2.88% 5,830,080
2026-11-02 26.30 26.34 24.60 24.69 -4.63% 6,596,751
2026-10-30 26.36 26.36 25.26 25.89 +3.11% 11,592,385
2026-10-29 24.52 25.40 23.94 25.11 +2.62% 4,158,106
2026-10-28 24.10 24.99 23.60 24.47 +0.25% 3,997,777
2026-10-27 25.10 25.56 24.12 24.41 -1.17% 3,143,805
2026-10-26 25.80 25.86 24.29 24.70 -3.36% 4,301,210
2026-10-23 24.35 25.56 23.14 25.56 +4.97% 6,735,805
2026-10-22 25.30 25.74 24.35 24.35 -4.99% 6,496,159
2026-10-21 26.97 27.00 25.63 25.63 -4.97% 3,740,841
2026-10-19 27.15 27.78 26.20 26.97 +0.45% 7,708,078
2026-10-16 27.41 28.56 26.22 26.85 -2.68% 11,573,707
2026-10-15 28.20 28.46 27.59 27.59 -4.99% 4,653,511
2026-10-14 30.97 30.99 29.04 29.04 -4.97% 12,163,347
2026-10-13 30.50 30.98 28.27 30.56 +3.56% 21,825,288
2026-10-12 29.51 29.51 28.69 29.51 +4.98% 10,771,809
2026-10-09 26.60 28.11 25.51 28.11 +4.97% 20,427,857
2026-10-08 26.78 27.83 26.78 26.78 -4.97% 20,145,752
2026-10-07 28.18 28.18 28.18 28.18 -4.99% 2,139,001
2026-10-06 29.66 31.22 29.66 29.66 -5.00% 11,979,158
2026-10-05 31.22 31.22 31.22 31.22 -4.99% 996,049
2026-10-01 32.86 32.86 32.86 32.86 -4.97% 1,444,357
2026-09-30 37.17 37.24 34.58 34.58 -4.97% 18,707,312
2026-09-29 36.39 36.39 35.50 36.39 +4.99% 9,537,815
2026-09-28 32.25 34.66 32.24 34.66 +10.00% 23,572,265
2026-09-25 28.78 31.51 27.71 31.51 +9.98% 80,210,539
2026-09-24 29.68 30.68 28.18 28.65 -3.47% 49,040,894
2026-09-23 30.30 31.29 26.55 29.68 +2.84% 113,090,092
2026-09-22 27.60 28.86 26.91 28.86 +9.98% 70,018,561
2026-09-21 23.16 27.48 23.15 26.24 +14.59% 130,243,729
2026-09-18 22.68 24.78 22.11 22.90 +4.85% 145,565,213
2026-09-17 19.70 22.36 19.70 21.84 +8.98% 49,745,313
2026-09-16 20.20 20.50 19.60 20.04 -0.69% 46,066,495
2026-09-15 21.05 22.94 19.37 20.18 +3.12% 165,056,337
2026-09-11 17.73 20.00 17.54 19.57 +11.57% 150,749,037
2026-09-10 16.41 18.00 16.05 17.54 +7.74% 31,629,564
2026-09-09 15.62 16.68 15.62 16.28 +4.29% 17,458,736
2026-09-08 15.54 15.69 15.41 15.61 +0.84% 1,454,613
2026-09-07 15.74 15.85 15.41 15.48 -1.28% 2,176,718
2026-09-04 15.68 15.89 15.54 15.68 +0.51% 2,049,674
2026-09-03 15.47 16.25 15.47 15.60 +0.26% 5,112,726
2026-09-02 15.49 15.76 15.32 15.56 +0.45% 1,668,193
2026-09-01 15.93 15.97 15.37 15.49 -2.33% 1,880,199
2026-08-31 16.10 16.25 15.58 15.86 -0.31% 3,294,080
2026-08-28 15.60 16.87 15.26 15.91 +1.99% 15,441,669
2026-08-27 15.10 15.80 15.10 15.60 +3.24% 4,430,962
2026-08-26 15.19 15.26 15.00 15.11 +0.40% 1,738,781
2026-08-25 15.45 15.45 14.97 15.05 -2.46% 1,384,779
2026-08-24 14.34 15.60 14.34 15.43 +8.05% 8,502,260
2026-08-21 14.37 14.64 14.22 14.28 -0.63% 1,740,886
2026-08-20 14.55 14.60 14.31 14.37 -1.10% 2,923,088
2026-08-19 14.60 14.70 14.38 14.53 -0.68% 2,031,806
2026-08-18 14.50 14.72 14.35 14.63 +0.83% 1,995,227
2026-08-17 14.45 14.65 14.25 14.51 +0.55% 2,297,801
2026-08-14 14.23 14.55 14.10 14.43 +1.26% 2,724,717
2026-08-13 14.23 14.43 14.10 14.25 +0.14% 1,314,643
2026-08-12 14.44 14.44 14.18 14.23 -1.25% 1,068,884
2026-08-11 14.59 14.59 14.36 14.41 -0.28% 1,335,679
2026-08-10 14.90 14.92 14.20 14.45 -0.69% 3,748,377
2026-08-07 14.14 14.70 13.97 14.55 +2.39% 3,203,483
2026-08-06 14.50 14.58 13.81 14.21 -1.93% 2,562,428
2026-08-05 14.68 14.68 14.40 14.49 -0.55% 1,335,671
2026-08-04 14.71 14.73 14.53 14.57 -0.95% 1,560,422
2026-08-03 14.45 14.85 14.45 14.71 +0.68% 1,760,550
2026-07-31 14.65 14.69 14.19 14.61 +0.62% 4,814,365
2026-07-30 15.85 15.88 14.18 14.52 -8.56% 23,886,257
2026-07-29 15.79 16.19 15.60 15.88 +1.60% 5,560,683
2026-07-28 15.80 15.98 15.50 15.63 -0.76% 1,891,458
2026-07-27 15.11 15.99 15.10 15.75 +4.93% 5,852,235
2026-07-24 14.94 15.15 14.81 15.01 -0.46% 2,826,907
2026-07-23 14.90 15.16 14.78 15.08 +1.41% 2,071,289
2026-07-22 15.37 15.50 14.83 14.87 -3.25% 2,173,862
2026-07-21 14.97 15.72 14.89 15.37 +2.47% 5,460,317
2026-07-20 14.73 15.15 14.61 15.00 +1.83% 2,505,634
2026-07-17 15.15 15.18 14.70 14.73 -2.96% 2,992,300
2026-07-16 15.09 15.36 14.95 15.18 +0.13% 3,088,810
2026-07-15 15.12 15.29 15.11 15.16 +0.73% 2,584,237
2026-07-14 15.29 15.47 14.99 15.05 -2.21% 3,277,859
2026-07-13 15.52 15.67 15.35 15.39 -1.28% 1,468,438
2026-07-10 15.64 15.72 15.50 15.59 +0.78% 1,951,504
2026-07-09 15.15 15.64 15.10 15.47 +1.84% 2,817,959
2026-07-08 15.53 15.57 15.00 15.19 -2.75% 3,871,039
2026-07-07 15.40 16.07 15.40 15.62 +1.96% 5,642,966
2026-07-06 15.84 15.92 15.26 15.32 -3.47% 4,134,166
2026-07-03 16.12 16.24 15.25 15.87 -0.19% 13,101,547
2026-07-02 15.96 16.14 15.85 15.90 +0.00% 3,450,989
2026-07-01 16.00 16.45 15.87 15.90 -0.56% 5,919,809
2026-06-30 16.37 16.50 15.89 15.99 -0.93% 3,489,328
2026-06-29 16.46 16.46 15.86 16.14 -0.92% 6,424,267
2026-06-25 16.29 16.73 16.21 16.29 +0.99% 7,009,180
2026-06-24 16.19 16.78 16.02 16.13 +0.44% 9,474,975
2026-06-23 16.00 16.75 15.86 16.06 +0.69% 12,914,893
2026-06-22 16.45 16.75 15.90 15.95 -2.15% 5,626,713
2026-06-19 15.69 16.45 15.63 16.30 +3.49% 6,640,407
2026-06-18 16.09 16.45 15.60 15.75 -1.50% 7,185,496
2026-06-17 16.19 16.39 15.78 15.99 -0.50% 8,257,668
2026-06-16 15.35 16.24 15.17 16.07 +5.45% 18,214,985
2026-06-15 15.35 15.62 14.90 15.24 +1.20% 10,062,459
2026-06-12 15.25 15.38 14.37 15.06 +0.33% 10,489,576
2026-06-11 14.55 15.25 14.07 15.01 +4.09% 11,863,140
2026-06-10 15.33 15.99 14.30 14.42 -4.76% 15,127,377
2026-06-09 14.17 15.29 14.01 15.14 +7.68% 27,568,229
2026-06-08 13.90 14.30 13.67 14.06 +0.57% 3,182,148
2026-06-05 14.36 14.64 13.90 13.98 -1.06% 5,062,948
2026-06-04 13.56 15.24 13.56 14.13 +2.99% 14,970,423
2026-06-03 13.48 13.83 13.48 13.72 +0.66% 967,460
2026-06-02 13.45 13.96 13.45 13.63 +0.29% 1,675,533
2026-06-01 13.98 13.98 13.50 13.59 -1.88% 1,039,501
2026-05-29 14.29 15.02 13.52 13.85 -2.81% 10,072,113
2026-05-27 14.18 14.35 14.00 14.25 +1.42% 1,541,657
2026-05-26 13.77 14.52 13.73 14.05 +1.96% 3,143,117
2026-05-25 13.99 14.19 13.70 13.78 -0.93% 869,177
2026-05-22 14.05 14.24 13.68 13.91 +0.14% 951,228
2026-05-21 13.44 14.40 13.35 13.89 +4.36% 4,173,135
2026-05-20 13.40 13.60 13.26 13.31 -1.19% 908,362
2026-05-19 13.69 13.76 13.35 13.47 -0.15% 961,897
2026-05-18 13.39 13.80 13.14 13.49 +1.05% 1,615,593

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 19 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Anlon Healthcare Limited, ISIN INE0Y8W01025.

Promoters and group
52.68%
0.00 pp vs Jun 2026
Public (all, Category B)
47.32%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group52.68%52.68%0.00 pp-0.00 ppNo material change.
Public (all, Category B)47.32%47.32%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
Punitkumar R RasadiaIndividuals Or HUF18,59,20,00034.98% 18,59,20,000
Meet Atulkumar VachhaniIndividuals Or HUF9,40,80,00017.70% 9,40,80,000
Shree Dwarikadhish Ventures LLPBodies Corporate4,00,00,0007.53% -
Ban Labs Private LimitedBodies Corporate2,80,00,0005.27% -
Luv Natwarlal UkaniResident Individual Shareholders Holding Nominal Share Capital In Excess Of Rs Two Lakh60,00,0001.13% -
Jay Mauleshkumar UkaniResident Individual Shareholders Holding Nominal Share Capital In Excess Of Rs Two Lakh60,00,0001.13% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202652.68%0.00 pp47.32%0.00 pp19 Oct 2026
Jun 2026 revised52.68%0.00 pp47.32%0.00 pp20 Jul 2026
Mar 202652.68%0.00 pp47.32%0.00 pp11 Apr 2026
Dec 202552.68%0.00 pp47.32%0.00 pp07 Jan 2026
Sep 202552.68%-47.32%-15 Oct 2025
Sep 2025 revised52.68%-47.32%-03 Sep 2025
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.